Answers are grounded in this paper and cite their sources.
The background and current context of work on the shikimate-pathway enzymes as potential targets for anti-bacterial, anti-fungal and anti-parasitic drugs is reviewed. Recent work on the third enzyme of the pathway, dehydroquinase, which occurs in two structurally and mechanistically distinct forms, is used to illustrate the present state of studies into rational drug design.
No takes yet. Share an insight, caveat, or question.
Coggins et al. (2003) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: